182 related articles for article (PubMed ID: 25809706)
21. Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage.
Koike H; Suzuki K; Satoh T; Ohtake N; Takei T; Nakata S; Yamanaka H
Anticancer Res; 2003; 23(6D):4947-51. PubMed ID: 14981950
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative.
McKay JA; Douglas JJ; Ross VG; Curran S; Murray GI; Cassidy J; McLeod HL
Int J Cancer; 2000 Oct; 88(1):77-81. PubMed ID: 10964085
[TBL] [Abstract][Full Text] [Related]
23. Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.
Sobti RC; Kaur P; Kaur S; Singh J; Janmeja AK; Jindal SK; Kishan J; Raimondi S
Cancer Genet Cytogenet; 2006 Oct; 170(2):108-14. PubMed ID: 17011980
[TBL] [Abstract][Full Text] [Related]
24. Significant Association of
Hsu PC; Pei JS; Chen CC; Chang WS; Chin YT; Huang TL; Yang JS; Wang YC; Chen JC; Hsu YN; Tsai CW; Bau DT
Anticancer Res; 2021 Oct; 41(10):4801-4806. PubMed ID: 34593429
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas.
Lewis RC; Bostick RM; Xie D; Deng Z; Wargovich MJ; Fina MF; Roufail WM; Geisinger KR
Cancer Res; 2003 Dec; 63(23):8549-53. PubMed ID: 14679024
[TBL] [Abstract][Full Text] [Related]
26. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
27. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
28. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
[TBL] [Abstract][Full Text] [Related]
29. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
Wang L; Habuchi T; Takahashi T; Mitsumori K; Kamoto T; Kakehi Y; Kakinuma H; Sato K; Nakamura A; Ogawa O; Kato T
Carcinogenesis; 2002 Feb; 23(2):257-64. PubMed ID: 11872630
[TBL] [Abstract][Full Text] [Related]
31. Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan.
Lin HH; Ke HL; Hsiao KH; Tsai CW; Wu WJ; Bau DT; Chang LL
Chin J Physiol; 2011 Jun; 54(3):196-202. PubMed ID: 21789902
[TBL] [Abstract][Full Text] [Related]
32. TCF7L2 and CCND1 polymorphisms and its association with colorectal cancer in Mexican patients.
Rosales-Reynoso MA; Arredondo-Valdez AR; Juárez-Vázquez CI; Wence-Chavez LI; Barros-Núñez P; Gallegos-Arreola MP; Flores-Martínez SE; Morán-Moguel MC; Sánchez-Corona J
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):13-20. PubMed ID: 27755946
[TBL] [Abstract][Full Text] [Related]
33. Association Between Polymorphism rs678653 in Human Cyclin D1 Gene (CCND1) and Susceptibility to Cancer: A Meta-Analysis.
Dai X; Zhang X; Wang B; Wang C; Jiang J; Wu C
Med Sci Monit; 2016 Mar; 22():863-74. PubMed ID: 26979757
[TBL] [Abstract][Full Text] [Related]
34. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
[TBL] [Abstract][Full Text] [Related]
36. Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma.
Warchoł T; Kruszyna L; Lianeri M; Roszak A; Jagodziński PP
Pathol Oncol Res; 2011 Mar; 17(1):133-7. PubMed ID: 20680537
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.
Zhang W; Gordon M; Press OA; Rhodes K; Vallböhmer D; Yang DY; Park D; Fazzone W; Schultheis A; Sherrod AE; Iqbal S; Groshen S; Lenz HJ
Pharmacogenet Genomics; 2006 Jul; 16(7):475-83. PubMed ID: 16788380
[TBL] [Abstract][Full Text] [Related]
38. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area.
Hussain S; M Y; Thakur N; Salam I; Singh N; Mir MM; Bhat MA; Siddiqi MA; Das BC; Bharadwaj M
Mol Carcinog; 2011 Jul; 50(7):487-98. PubMed ID: 21268129
[TBL] [Abstract][Full Text] [Related]
39. Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer.
Le Marchand L; Seifried A; Lum-Jones A; Donlon T; Wilkens LR
JAMA; 2003 Dec; 290(21):2843-8. PubMed ID: 14657069
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
